75N91022C00013
Definitive Contract
Overview
Government Description
CLINICAL TRIALS MONITORING SERVICE
Awardee
Awarding / Funding Agency
Place of Performance
Princeton, NJ 8540 United States
Pricing
Cost Plus Fixed Fee
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Related Opportunity
Analysis Notes
COVID-19 $511,847 (2%) percent of this Definitive Contract was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021.
Undisclosed Subcontractors No subcontract awards have been formally disclosed for this contract; however, based on invoice data these subcontractors have worked on this contract: Connexus Technology, Aitheras
Undisclosed Subcontractors No subcontract awards have been formally disclosed for this contract; however, based on invoice data these subcontractors have worked on this contract: Connexus Technology, Aitheras
Theradex Systems was awarded
Definitive Contract 75N91022C00013 (75N910-22-C-00013)
for Clinical Trials Monitoring Service
worth up to $164,735,124
by National Cancer Institute
in May 2022.
The contract
has a duration of 10 years and
was awarded
through solicitation Clinical Trials Monitoring Service (CTMS)
with a Small Business Total set aside
with
NAICS 541715 and
PSC AN13
via direct negotiation acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $136,706,899 and funded backlog of $12,381,916.
Status
(Open)
Last Modified 3/14/25
Period of Performance
5/1/22
Start Date
4/30/26
Current End Date
4/30/32
Potential End Date
Obligations and Backlog
$28.0M
Total Obligated
$40.4M
Current Award
$164.7M
Potential Award
$12.4M
Funded Backlog
$136.7M
Total Backlog
Award Hierarchy
Definitive Contract
75N91022C00013
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 75N91022C00013
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2022 | $410,830 | 7,175.0 | 3.4 | $57.26 |
| 2023 | $7,382,896 | 53,519.5 | 25.7 | $137.95 |
Opportunity Lifecycle
Procurement history for 75N91022C00013
Transaction History
Modifications to 75N91022C00013
People
Suggested agency contacts for 75N91022C00013
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
HFYTJGWFPMR7
Awardee CAGE
1XAJ3
Agency Detail
Awarding Office
75N910 NIH NCI
Funding Office
75N910
Created By
hhscshih
Last Modified By
hhscshih
Approved By
hhscshih
Legislative
Legislative Mandates
Labor Standards
Performance District
NJ-12
Senators
Robert Menendez
Cory Booker
Cory Booker
Representative
Bonnie Watson Coleman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Research and development contracts (25.5) | $16,255,508 | 97% |
| Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) | Health care services | Research and development contracts (25.5) | $511,847 | 3% |
Modified: 3/14/25